Innate Pharma

IPHA

Valor de mercado US$ 154 mi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
1	1 BlackRock New York	US$ 965 mil	-US$ 39,5 mil	-14.630	-3%
2	2 Optiver Holding Amsterdam, Netherlands	US$ 371 mil	+US$ 9,08 mil	+3.366	+2%
3	3 Bank of America Charlotte, North Carolina	US$ 330 mil	-US$ 28,2 mil	-10.451	-6%
4	4 Morgan Stanley New York	US$ 114 mil	+US$ 27,7 mil	+10.254	+22%
5	5 Two Sigma Investments New York	US$ 38 mil	-US$ 17,5 mil	-6.500	-26%
6	6 Balyasny Asset Management Chicago, Illinois	US$ 32 mil	+US$ 43,4 mil	+16.094	Nova
7	7 Millennium Management New York	US$ 29 mil	-US$ 6 mil	-2.222	-13%
8	8 UBS Group Zurich, Switzerland	US$ 9 mil	+US$ 4,18 mil	+1.549	+52%
9	9 Steward Partners Investment Advisory New York	US$ 1 mil	–	–	–
10	10 Tower Research Capital (TRC) New York	–	-US$ 7 mil	-2.600	Encerrada
11	11 Barclays London, United Kingdom	–	-US$ 5,55 mil	-2.056	-94%
12	12 Credit Suisse Zurich, Switzerland	–	-US$ 5 mil	-1.981	Encerrada
13	13 CAPTRUST Financial Advisors Raleigh, North Carolina	–	-US$ 2 mil	-905	Encerrada
14	14 Citigroup New York	–	-US$ 3	-1	-2%
15	15 Royal Bank of Canada Toronto, Ontario, Canada	–	+US$ 478	+177	Nova